Key facts
- This page summarizes Bull Horn Holdings Sponsor LLC's Form 4 filing for Coeptis Therapeutics Holdings, Inc. (COEP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 01 Nov 2022, 21:30.
Bull Horn Holdings Sponsor LLC - 28 Oct 2022 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- COEP
- Reported as of
- 28 Oct 2022
- Net transaction value
- +$3,000,000
- Reporting owner signature
- /s/ Christopher Calise, as managing member of Bull Horn Holdings Sponsor LLC
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Bull Horn Holdings Sponsor LLC filed Form 4 for Coeptis Therapeutics Holdings, Inc. (COEP) on 01 Nov 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$3,000,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
COEP
transaction
Derivative
Warrant
Award
- Transaction value
- $3,000,000
- Shares
- +3,000,000
- Change %
- Price
- $1.00
- Shares after
- 3,000,000
- Date
- 28 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000,000
- Exercise price
- $11.50
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On October 28, 2022, Bull Horn Holdings Corp. ("Bull Horn") completed its initial business combination with Coeptis Therapeutics, Inc., a Delaware corporation ("Coeptis"), and changed its name to Coeptis Therapeutics Holdings, Inc., pursuant to that certain Agreement and Plan of Merger, dated as of April 18, 2022.
Footnote F2
Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of Bull Horn. The warrants could only become eligible for exercise upon consummation of Bull Horn's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of Bull Horn's initial business combination with Coeptis.
Footnote F3
The Sponsor is the record holder of the warrants reported herein. Christopher Calise and Robert Striar are the managing members of the Sponsor and have voting and dispositive power over the warrants held by the Sponsor. Each of Mr. Calise and Mr. Striar disclaims any beneficial ownership of the reported warrants other than to the extent of any pecuniary interest he may have therein.
SEC remarks
On October 27, 2022, Bull Horn Holdings Corp., a Delaware corporation, became the successor of Bull Horn Holdings Corp., a British Virgin Islands business company, pursuant to a domestication. The merger had the effect of changing Bull Horn Holdings Corp.'s domicile, but did not alter the proportionate interests of security holders.